Connect your AI

Castle Biosciences CSTL Allowance for Credit Losses on Held-to-Maturity Securities

Allowance for Credit Losses on Held-to-Maturity Securities at other companies

Great Southern BancorpGSBC

-$570K-78.1%

Financial InstitutionsFISI

$2K0.0%

Trustco Bank CorpTRST

$0—

Heritage FinancialHFWA

$0—

Banner CorporationBANR

-$285K+2.4%

WesBancoWSBC

$151K+10.2%

Other financials

Income statement

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLoss.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's allowance for credit losses on held-to-maturity securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Castle Biosciences's allowance for credit losses on held-to-maturity securities?: Castle Biosciences (CSTL) reported allowance for credit losses on held-to-maturity securities of $0 in Q1 2026.